Your browser version may not work well with NCBI's Web applications. More information here...
1: Cancer Cell. 2005 Jul;8(1):61-74.Click here to read Links
Comment in:
Future Oncol. 2005 Dec;1(6):763-6.

Heat shock phenocopies E1B-55K late functions and selectively sensitizes refractory tumor cells to ONYX-015 oncolytic viral therapy.

O'Shea CC, Soria C, Bagus B, McCormick F.

Cancer Research Institute, University of California, San Francisco, CA 94115, USA. coshea@cc.ucsf.edu

ONYX-015 is an E1B-55K-deleted adenovirus that has promising clinical activity as a cancer therapy. However, many tumor cells fail to support ONYX-015 oncolytic replication. E1B-55K functions include p53 degradation, RNA export, and host protein shutoff. Here, we show that resistant tumor cell lines fail to provide the RNA export functions of E1B-55K necessary for ONYX-015 replication; viral 100K mRNA export is necessary for host protein shutoff. However, heat shock rescues late viral RNA export and renders refractory tumor cells permissive to ONYX-015. These data indicate that heat shock and late adenoviral RNAs may converge upon a common mechanism for their export. Moreover, these data suggest that the concomitant induction of a heat shock response could significantly improve ONYX-015 cancer therapy.

PMID: 16023599 [PubMed - indexed for MEDLINE]

Related Articles